Patients with acute urinary tract infection are usually seen and treated by their family doctor, and the majority either do not stay away from work or return to work as soon as the symptoms are relieved. Though a seven-day course of treatment with a number of antimicrobial agents will eradicate most infections, the relief of symptoms and return to normal activities results in some patients not completing the full course. This leads to a number of infections persisting in an asymptomatic form.
Sulphormethoxine (Fanasil) is a sulphonamide with a halflife in the body of about 150-200 hours (Haegi, 1966) , and if therefore a seven-day course is required a single-dose treatment is feasible.
We have carried out a trial to compare this treatment with a seven-day course of ampicillin, which is established as an effective treatment of primary urinary tract infection.
Materials and Methods
Examination of Urine.-Midstream specimens of urine were collected by the clean-catch technique after cleansing with a swab moistened in sterile water. Quantitative bacterial and white cell counts were carried out. The sole criterion of infection was a count of 100,000 bacteria or more per ml. of urine. Organisms were identified by conventional methods, and the 0 antigen of Escherichia coli strains was identified by means of specific antisera.
Serum Antibodies.-Antibodies in the patient's serum against infecting organisms were estimated as previously described (Percival, Brumfitt, and de Louvois, 1964 Treatment was judged to have been successful if both follow-up specimens of urine were sterile, and to have failed where the organism originally isolated persisted.
Results
Treatment was given to 104 patients who had typical symptoms, but examination of the urine showed that only 50 of these had significant bacteriuria ; therefore assessment of the relative chemotherapeutic value of sulphormethoxine and ampicillin was confined to the latter group of patients. Table II shows that cure rates were the same with sulphormethoxine and ampicillin, both substances being successful in 22 (88%) of the 25 patients in each group. The three patients who failed to respond to ampicillin all had very high serum antibody titres against the infecting organism, which suggested extensive renal tissue involvement. In two of the three ampi- Rashes occurred in five patients and were maximal on the arms and trunk and non-pruritic. The rashes did not intensify when treatment was continued, and no urticarial rash characteristic of classical penicillin hypersensitivity was seen. Details of the actual side-effects are given in Table IV . They were equally distributed between patients who had true urinary infection and those who had typical symptoms without infected urine. Interestingly, three patients who had typical symptoms but no infection when treatment was started were found to be infected at follow-up. One of these patients was subsequently found to have a urinary tract abnormality, and the other two infections were due to organisms resistant to the antibacterial substance used.
Discussion
In a previous study carried out in general practice we found that a seven-day course of sulphadimidine cured 90 % of patients with acute urinary tract infection (Mond, Percival, Williams, and Brumfitt, 1965) , and in the present investigation 22 out of 25 patients were cured by the long-acting sulphonamide, sulphormethoxine, given in a single dose of 2 g. Ampicillin in conventional dosage cured the same number of patients with similar infections (Tables I and II) .
The side-effects of ampicillin were more frequent than those due to sulphormethoxine, but it should be stressed that many of these would be accepted by patients confined to their home. However, effective treatment of patients with less severe clinical forms of urinary infection enabled them to resume normal activities, and under these circumstances side-effects were sometimes troublesome. For example, one patient who returned to work in a factory was unable to continue because of diarrhoea. Patients with side-effects also tend to discontinue the treatment.
The rashes which occurred after ampicillin have been ascribed to hypersensitivity (British Medical 7ournal, 1964) , but the evidence for this is uncertain. The rashes were not urticarial and there were none of the other signs usually associated with penicillin hypersensitivity. Furthermore, in such patients skin tests can subsequently be shown to be negative (Stewart, personal communication).
With sulphormethoxine only a single dose was necessary, and therefore there was no danger of the patient forgetting or deliberately omitting to take the treatment. Side-effects were minimal, and many patients remarked favourably on the simplicity of treatment-particularly those who had previously been treated with other courses.
Previous studies have shown that where minimal inhibitory concentrations of sulphonamide are below 50 jug./ml. eradication of urinary infection can be expected, while minimal inhibitory concentrations in excess of 200 [g./ml. usually mean that the infection will prove to be resistant to sulphonamides. We found that 82 % of organisms were sensitive to 50 lg. of sulphormethoxine per ml. or lesse and these results agreed exactly with those found with sulphadimidine. It was also found that 87% of the organisms were sensitive to 5 fig. of ampicillin per ml. or less.
In the present study failure to respond to treatment was due to resistance of the infecting organism or to the presence of urinary tract abnormalities, and the three patients with sensitive organisms who failed to respond to both sulphormethoxine and ampicillin were all found to have such abnormalities when investigated radiologically.
There has recently been much discussion about the association of long-acting sulphonamides and the Stevens-Johnson syndrome (Carroll, Bryan, and Robinson, 1966 ; Harris, Wise, and Beveridge, 1966; Seneca, 1966) . The syndrome may have a special association with sulphamethoxypyridazine, and it is said to be especially apt to occur in children (Harris et al., 1966) . Sulphonamides in general, together with a variety of other substances, have been associated with the Stevens-Johnson syndrome, but over the past five years we have observed several thousand patients treated with sulphadimidine and the longacting compound sulphamethoxydiazine but have seen no example of the condition. Clearly a new compound must be used cautiously, and in view of the claim that the StevensJohnson syndrome is more likely to occur in children it would be best to avoid sulphormethoxine in paediatric practice until more experience has been gained in its use.
Recent but as yet unpublished experience on a very large scale during an outbreak of meningococcal meningitis, in which sulphormethoxine was used prophylactically in very high and repeated doses, has shown that the drug can occasionally produce skin reactions. These usually occurred in children, were mild, and followed a benign course. In some cases, however, they were generalized, more severe, and showed features of Lyell's syndrome (I. Lennox-Smith, personal communication) .
The evidence that long-acting sulphonamides produce a more sustained hypersensitivity reaction than the short-acting compounds is in our view unimpressive, but of course no patient with a history of sulphonamide sensitivity must receive the compound.
Our findings suggest that for treatment of patients with urethrotrigonitis, such as we have described here, results will be as good as with the other antimicrobials at present available, while the side-effects and inconvenience to the patient are likely to be minimal.
In our view a long-acting compound of this variety is unsuitable for the treatment of patients with fever and evidence of acute pyelonephritis. Also, asymptomatic urinary infections in diabetic patients and pregnant women are more difficult to eradicate than the acute infections seen in general practice (Williams, Brumfitt, Leigh, and , and the possible place of sulphormethoxine in these conditions remains to be defined.
SUmmary
Sulphormethoxine is a sulphonamide with a prolonged action, which makes possible the treatment of some varieties of acute urinary tract infection with a single dose of 2 g. In a controlled trial on ambulant patients it was as effective as a seven-day course of ampicillin given in a dose of 500 mg. eight-hourly. The cure rate was 88% with both substances. Side-effects occurred in 3.8% of patients treated with sulphormethoxine and in 16.1% of those who received ampicillin.
Sulphormethoxine is not recommended for acute pyelonephritis.
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